renal hemosiderosis among iranian transfusion dependent β-thalassemia major patients
نویسندگان
چکیده
background: in recent years, the success in management of thalassemic patients, has allowed for some previously unrecognized complications including renal abnormalities to emerge. this prospective study aimed to investigate kidney iron overload by means of mri t2* and also renal function based on laboratory tests for early markers of glomerular and tubular dysfunction among adult iranian transfusion-dependent thalassemia major patients. subjects and methods: two-hundred and two patients with transfusion-dependent β-thalassemia major were included in this study in zafar adult thalassemia center, tehran, iran. for all patients, kidney mri t2* as well as evaluation of bun, creatinine, uric acid, calcium, phosphorus, sodium (na), potassium (k), total protein, albumin, cystatin c, serum ferritin β2-microglobulin, nag (n-acetyl-beta-d-glucosaminidase), and urine protein were performed. results: one-hundred and fourteen female and 88 male transfusion-dependent β-thalassemia major patients with mean age of 30.1 ± 9.4 participated in the present study. we found that 77.7% of our patients had kidney hemosiderosis based on mri t2*. also, 67 patients (33.2%) had elevation of serum cystatin c, and 104 patients (51.5%) had reduced estimated glomerular filtration rate (e-gfr). increased urinary excretion of nag and hypercalciuria were found in 50% and 79.2% of participants, respectively. conclusion: renal hemosiderosis and asymptomatic renal dysfunction are prevalent among transfusion- dependent β-thalassemia major patients which necessitate regular screening with early markers of glomerular and tubular dysfunction. further studies in order to investigate the correlation between renal hemosiderosis and early markers of kidney dysfunction among these patients are recommended.
منابع مشابه
Renal Hemosiderosis among Iranian Transfusion Dependent β-Thalassemia Major Patients
Background: In recent years, the success in management of thalassemic patients, has allowed for some previously unrecognized complications including renal abnormalities to emerge. This prospective study aimed to investigate kidney iron overload by means of MRI T2* and also renal function based on laboratory tests for early markers of glomerular and tubular dysfunction among adult Iranian transf...
متن کاملβ-Thalassemia Mutations among Transfusion-Dependent Thalassemia Major Patients in Northern Iraq
Molecular defects responsible for β-thalassemias (thal) were investigated among 254 chromosomes from 127 transfusion-dependent unrelated thalassemic patients from two provinces in Northern Iraq. Among fourteen identified mutations, the seven most common found in 88.2% of the thal chromosomes were: IVS-II-1 (G → A), IVS-I-1 (G → A), codon 8 (-AA), codon 39 (G → T), codon 8/9 (+G), codon 44 (-C),...
متن کاملPulmonary dysfunction in transfusion-dependent patients with thalassemia major.
Pulmonary function tests were performed on 62 transfusion-dependent patients with thalassemia major, ranging in age from 8 to 33 years, and receiving chelation therapy with desferrioxamine or deferiprone. Percent predicted values for FVC, FEV1, and PEF were significantly reduced, whereas FEV1/FVC and maximal expiratory flow at 25% FVC were within normal limits, indicating a restrictive disease....
متن کاملHydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
BACKGROUND β-Thalassemia is an inherited hemoglobin disorder caused by defective synthesis of ß-globin chains. Hemoglobin (Hb) F induction is a possible therapeutic approach which can partially compensate for α and non-α globin chains imbalance. OBJECTIVES We aimed to investigate the efficacy and safety of Hydroxyurea (HU) in diminishing transfusion requirements of patients with β-thalassemia...
متن کاملPrevalence of Diabetes Mellitus in Patients with Transfusion Dependent β Thalassemia
Introduction: Thalassemia is common in Iran. Appropriate therapy for this disease includes a regular blood transfusion and chelation therapy. However, patients will inevitably confront with side effects, particularly iron overloads in critical organ including heart, ductless glands and liver. This study tries to determine the prevalence of diabetes mellitus in transfusion dependent β thalassemi...
متن کاملsurvival analysis of transfusion dependent î²-thalassemia major patients
background: the classical supportive therapy for î² -thalassemia major consists of regular blood transfusion, iron-chelation therapy and specific treatment of the related complications. a balance between the maintenance of the highest possible level of haemoglobin and lowest possible level of iron accumulation in heart and liver give the best chance of survival and the best quality of life. met...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
international journal of hematology-oncology and stem cell researchجلد ۱۱، شماره ۲، صفحات ۱۳۳-۱۳۸
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023